Aquestive Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 31807000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Aquestive Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:35:21.415897+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/91cd372b-bb32-4da5-bfcb-26e202d690be
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001140361-21-007811Retrieved: 2026-08-19T13:35:21.415897+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001398733/cash-and-equivalents/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/91cd372b-bb32-4da5-bfcb-26e202d690be
History
- no predecessors — first report